Standout Papers

Cancer immunotherapy comes of age 2001 2026 2009 2017 3.0k
  1. Cancer immunotherapy comes of age (2011)
    Ira Mellman, George Coukos et al. Nature
  2. Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer (2003)
    Lin Zhang, José R. Conejo-García et al. New England Journal of Medicine
  3. Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance (2019)
    Filipe Martins, Sofiya Latifyan et al. Nature Reviews Clinical Oncology
  4. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells (2011)
    Andrea Facciabene, Xiaohui Peng et al. Nature
  5. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. (2001)
    E.Y. Woo, Christina Chu et al. PubMed
  6. microRNAs exhibit high frequency genomic alterations in human cancer (2006)
    Lin Zhang, Jia Huang et al. Proceedings of the National Academy of Sciences
  7. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis (2008)
    Qihong Huang, Kiranmai Gumireddy et al. Nature Cell Biology
  8. Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors (2014)
    Gregory T. Motz, Stephen P. Santoro et al. Nature Medicine
  9. T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis (2012)
    Andrea Facciabene, Gregory T. Motz et al. Cancer Research
  10. Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments (2009)
    Ilona Kryczek, Mousumi Banerjee et al. Blood
  11. Modulation of the antitumor immune response by complement (2008)
    Maciej M. Markiewski, Robert A. DeAngelis et al. Nature Immunology
  12. Laser-capture microdissection (2006)
    Virginia Espina, Julia Wulfkuhle et al. Nature Protocols
  13. Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis (2011)
    Wei‐Ting Hwang, Sarah F. Adams et al. Gynecologic Oncology
  14. Deciphering and Reversing Tumor Immune Suppression (2013)
    Greg Motz, George Coukos Immunity
  15. Radiotherapy combination opportunities leveraging immunity for the next oncology practice (2016)
    Fernanda Herrera, Jean Bourhis et al. CA A Cancer Journal for Clinicians
  16. Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion (2020)
    Yi-Ru Yu, Hana Imrichová et al. Nature Immunology
  17. Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function (2019)
    Selena Viganó, Dimitrios Alatzoglou et al. Frontiers in Immunology
  18. Interpretation of T cell states from single-cell transcriptomics data using reference atlases (2021)
    Massimo Andreatta, Jesús Corría-Osorio et al. Nature Communications
  19. Novel strategies to manage CAR-T cell toxicity (2025)
    Lionel Trueb, George Coukos et al. Nature Reviews Drug Discovery

Immediate Impact

5 by Nobel laureates 51 from Science/Nature 228 standout
Sub-graph 1 of 16

Citing Papers

Targeting protein–ligand neosurfaces with a generalizable deep learning tool
2025 StandoutNature
CAR immune cells: design principles, resistance and the next generation
2023 StandoutNature
11 intermediate papers

Works of George Coukos being referenced

A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T-cell therapy
2020
Primary Human Ovarian Epithelial Cancer Cells Broadly Express HER2 at Immunologically-Detectable Levels
2012
and 10 more

Author Peers

Author Last Decade Papers Cites
George Coukos 16776 17255 12693 392 34.6k
Jeffrey W. Pollard 29458 19460 20076 248 53.9k
Frances R. Balkwill 18138 22155 13853 291 46.0k
Steven Μ. Albelda 13327 12913 10474 314 34.7k
Weiping Zou 19426 16526 10603 185 34.3k
Theresa L. Whiteside 20090 13573 16266 602 38.6k
David T. Scadden 10234 10085 18435 382 42.8k
Harold F. Dvorak 6933 9847 24197 274 47.1k
Jérôme Galon 18640 22017 11031 239 38.7k
Soldano Ferrone 21514 13716 10404 858 34.4k
Michael A. Caligiuri 25583 13716 13372 436 45.8k

All Works

Loading papers...

Rankless by CCL
2026